Show simple item record

dc.contributor.authorCatalá-López, Ferrán 
dc.contributor.authorHutton, Brian
dc.contributor.authorPage, Matthew J
dc.contributor.authorRidao, Manuel
dc.contributor.authorDriver, Jane A
dc.contributor.authorAlonso-Arroyo, Adolfo
dc.contributor.authorForés-Martos, Jaume
dc.contributor.authorMacías Saint-Gerons, Diego
dc.contributor.authorVieta, Eduard
dc.contributor.authorValencia, Alfonso 
dc.contributor.authorTabarés-Seisdedos, Rafael
dc.identifier.citationSyst Rev. 2017;6(1):189.es_ES
dc.description.abstractBACKGROUND: Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) are childhood onset neurodevelopmental disorders that may persist into adulthood. ASD and ADHD tend to run in families and may have a significant negative impact on the health and longevity of those with the disorder and their relatives. The aim of this study will be to analyze the risk of mortality among children, adolescents, and adults with ASD or ADHD and their first-degree relatives. METHODS/DESIGN: We will conduct a systematic review and meta-analysis of observational studies. Searches of PubMed/MEDLINE, EMBASE, PsycINFO, SCOPUS, and ISI Web of Science will be used to identify epidemiological studies. Eligible studies will be observational studies reporting study-specific data for all-cause mortality or cause-specific mortality in children, adolescents, or adults with ASD or ADHD and/or their first-degree relatives. Cohort studies and case-control studies will be included. The primary outcome will be all-cause mortality. The secondary outcome will be cause-specific mortality. Two reviewers will independently screen references identified by the literature search, as well as potentially relevant full-text articles. Data will be abstracted, and study risk of bias/methodological quality will be appraised by two reviewers independently. The methodological quality of epidemiological studies will be appraised using the Newcastle-Ottawa Scale (NOS). Conflicts at all levels of screening and abstraction will be resolved through discussion. Random-effects meta-analyses of primary studies will be conducted where appropriate. Subgroup analyses for exploring statistical heterogeneity, if feasible, will include gender, age group, ethnicity, comorbidities, classification of cause of death, and relevant study characteristics. DISCUSSION: Our study will establish the extent of the epidemiological evidence underlying the risk of mortality among children, adolescents, and adults with ASD or ADHD and their first-degree relatives. We anticipate that our findings will be of interest to patients, their families, caregivers, healthcare professionals, scientists, and policy makers. Implications for future epidemiological research will be discussed. SYSTEMATIC REVIEW REGISTRATION: PROSPERO CRD42017059955 .es_ES
dc.description.sponsorshipFC-L and RT-S are funded by the Generalitat Valenciana (PROMETEOII/2015/021) and CIBERSAM/Institute of Health Carlos III. BH is supported by a New Investigator Award from the Canadian Institutes of Health Research and the Drug Safety and Effectiveness Network. MJP is supported by an Australian National Health and Medical Research Council Early Career Fellowship (1088535). MR is partially funded by the Spanish Health Services Research on Chronic Patients Network (REDISSEC)/Institute of Health Carlos III. None of the funders were involved in the design of the protocol and decision to submit the protocol for publication, nor will they be involved in any aspect of the conduct of the review. The views expressed in this article are the views of the authors and may not be understood or quoted as being made on behalf of, or reflecting the position of, the funder(s) or any institution.es_ES
dc.relation.isversionofPublisher's versiones_ES
dc.subjectAttention deficit hyperactivity disorderes_ES
dc.subjectAutism spectrum disorderses_ES
dc.subjectChild developmentes_ES
dc.subjectNeurodevelopmental disorderses_ES
dc.subjectSystematic reviewes_ES
dc.subject.meshAdolescent es_ES
dc.subject.meshAdult es_ES
dc.subject.meshChild es_ES
dc.subject.meshFemale es_ES
dc.subject.meshHumans es_ES
dc.subject.meshMale es_ES
dc.subject.meshResearch Design es_ES
dc.subject.meshRisk es_ES
dc.subject.meshSystematic Reviews as Topic es_ES
dc.subject.meshAttention Deficit Disorder with Hyperactivity es_ES
dc.subject.meshAutism Spectrum Disorder es_ES
dc.subject.meshCause of Death es_ES
dc.subject.meshFamily es_ES
dc.titleRisk of mortality among children, adolescents, and adults with autism spectrum disorder or attention deficit hyperactivity disorder and their first-degree relatives: a protocol for a systematic review and meta-analysis of observational studieses_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.contributor.funderGeneralitat Valencianaes_ES
dc.contributor.funderInstituto de Salud Carlos III - ISCIII (España)es_ES
dc.contributor.funderCanadian Institutes of Health Research (CIHR)es_ES
dc.contributor.funderDrug Safety and Effectiveness Networkes_ES
dc.contributor.funderNational Health and Medical Research Council of Australia (NHMRC)es_ES
dc.contributor.funderSpanish Health Services Research on Chronic Patients Network (REDISSEC)es_ES
dc.relation.publisherversion 10.1186/s13643-017-0581-9.es_ES
dc.identifier.journalSystematic reviewses_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Antiguos CNIOes_ES

Files in this item

Acceso Abierto

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional